Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 5/20 | 0.51 |
| ▸ | SSTR5 | P35346 | 5/20 | 0.51 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.51 |
| ▸ | SSTR1 | P30872 | 3/20 | 0.51 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.51 |
| ▸ | KDM4A | O75164 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | MC4R | P32245 | 9/20 | 0.45 |
| ▸ | MC5R | P33032 | 9/20 | 0.45 |
| ▸ | MC3R | P41968 | 9/20 | 0.45 |
| ▸ | MC1R | Q01726 | 9/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29925316 | 1.00 | SSTR2 (0.51) | SSTR2SSTR5SSTR3SSTR1SSTR4 | |
| SCHEMBL29925290 | 1.00 | SSTR2 (0.51) | SSTR2SSTR5SSTR3SSTR1SSTR4 | |
| SCHEMBL29925429 | 1.00 | SSTR2 (0.51) | SSTR2SSTR5SSTR3SSTR1SSTR4 | |
| SCHEMBL29924816 | 1.00 | SSTR2 (0.51) | SSTR2SSTR5SSTR3SSTR1SSTR4 | |
| SCHEMBL29925303 | 1.00 | SSTR2 (0.51) | SSTR2SSTR5SSTR3SSTR1SSTR4 | |
| SCHEMBL29925512 | 0.87 | TPSAB1 (0.40) | KDM4A | |
| SCHEMBL29925126 | 0.87 | TPSAB1 (0.40) | KDM4A | |
| SCHEMBL29925086 | 0.87 | TPSAB1 (0.40) | KDM4A | |
| SCHEMBL29925039 | 0.87 | TPSAB1 (0.40) | KDM4A | |
| SCHEMBL29925101 | 0.87 | TPSAB1 (0.40) | KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | AJK BIOPHARMACEUTICAL LLC (US) | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | VIP, HM13, NGLY1 | SSTR2 2093/4885SSTR5 1501/4885SSTR3 1298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.